References
- Molina J. F., Espinzoa L. R. Relapsing polychondritis. Bailliere's Best Pract Res Clin Rheumatol 2000; 14: 97–109
- Buckner J. H., Van Landeghen M., Kwok W. W., Tsarnaridis L. Identification of type II collagen peptide 261‐273‐specific T cell clones in patients with relapsing polychondritis. Arthritis Rheum 2002; 46: 238–44
- Mpofu S., Estrach C., Curtis J., Moots R. J. Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab. Rheumatology 2003; 42: 1117–18
- Saadoun D., Deslandre C. J., Allanore Y., Charlier C., Pham X. V., Kahah A. Sustained response to infliximab in 2 patients with refractory relapsing polychondritis. J Rheumatol 2003; 30: 1394–5
- Richez C., Dumoulin C., Coutouly X., Schaeverbeke T. Successful treatment of relapsing polychondritis with infliximab. Clin Exp Rheumatol 2004; 22: 629–31
- Cazabon S., Over K., Butcher J. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis. Eye 2005; 19: 222–4
- Carter J. D. Treatment of relapsing polychondritis with a TNF antagonist. J Rheumatol 2005; 32: 1413